IP Library › Granted Patent US 9,567,385
Granted Patent B2
US 9,567,385 · App. 14/508,118 · Granted Feb 14, 2017

Modified acidic fibroblast growth factors and composition thereof

Inventor: Ya-Hui Lee (New Taipei, TW)
Assignee: EU SOL BIOTECH CO., LTD.
C07K14/501A61K38/1825
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,567,385
App. No.
14/508,118
Granted
Feb 14, 2017
Kind
B2
Abstract

The present invention provides acidic fibroblast growth factor (aFGF) composition, comprising: (i) aFGF of SEQ ID NO: 1, (ii) aFGF of SEQ ID NO: 1 having an N-terminal phosphogluconoylation, (iii) aFGF of SEQ ID NO: 1 having an N-terminal gluconoylation, (iv) aFGF of SEQ ID NO: 2 and (v) aFGF of SEQ ID NO: 3, or a combination thereof. Also provided is a modified acidic fibroblast growth factor (aFGF) which has an N-terminal phosphogluconoylation or gluconoylation.

Claims (4)

1. A peptide consisting of the modified acidic fibroblast growth factor (aFGF) of SEQ ID NO: 1 where the N-terminal is phosphogluconoylated.

2. A peptide consisting of the modified acidic fibroblast growth factor (aFGF) of SEQ ID NO: 1 where the N-terminal is gluconoylated.

3. A peptide consisting of the modified acidic fibroblast growth factor (aFGF) of SEQ ID NO: 2.

4. A peptide consisting of the modified acidic fibroblast growth factor (aFGF) of SEQ ID NO: 3.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2014
From: LEE, YA-HUI
To: EU SOL BIOTECH CO., LTD.
Reel/Frame 034548/0694 →
Continuity (2)
Provisional Application 61887619 · Oct 7, 2013
Related Publication 20150099701A1 · Apr 9, 2015